Page last updated: 2024-11-06

1,3-bis(diphenylphosphino)propane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-bis(diphenylphosphino)propane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID81219
CHEMBL ID73394
SCHEMBL ID35092
MeSH IDM0441670

Synonyms (80)

Synonym
AC-4967
44r56e2c68 ,
propane-1,3-diylbis(diphenylphosphine)
einecs 229-791-2
phosphine, 1,1'-(1,3-propanediyl)bis(1,1-diphenyl-
unii-44r56e2c68
nsc 193753
phosphine, 1,3-propanediylbis(diphenyl-
dppp cpd
6737-42-4
phosphine, trimethylenebis[diphenyl-
trimethylenebis(diphenylphosphine)
1,3-bis(diphenylphosphino)propane
phosphine,3-propanediylbis[diphenyl-
nsc-193753
nsc193753
1,3-propanediylbis[diphenylphosphine]
bis(1,3-diphenylphosphino)propane
1,3-bis(diphenylphosphino)propane, 97%
B1138
CHEMBL73394
3-diphenylphosphanylpropyl(diphenyl)phosphane
3-diphenylphosphanylpropyl(diphenyl)phosphane;dppp, 1,3-bis(diphenylphosphino)propane
A835727
AKOS004909020
[3-(diphenylphosphanyl)propyl]diphenylphosphane
FT-0606575
GC10105
1,3-bis(diphenylphosphino)propane (dppp)
phosphine, 1,3-propanediylbis[diphenyl-
1,3-bis-(diphenylphosphino)propane
SCHEMBL35092
SY006192
mfcd00003050
1,3-bis(diphenylphosphino)-propane
1,3-bisdiphenylphosphinopropane
1,3-bis(diphenyl phosphino)propane
1-((3-(diphenylphosphino)propyl)(phenyl)phosphino)benzene
1,3-bis(diphenyphosphino)propane
1.3-bis-diphenylphosphinopropane
1,3-bis(di-phenyl-phosphino)propane
1,3-bis-(diphenylphosphino)-propane
propane-1,3-diylbis(diphenyl phosphine)
1,3-bis diphenylphosphinopropane
1,3-bis-(diphenylphosphine) propane
1,3-bis(diphenyl-phosphino)propane
1,3-bis(diphenyl-phospino)propane
1,3-bis-(diphenylphosphine)propane
3-diphenylphosphanylpropyl-diphenyl-phosphane
1,3-bis(diphenylphospino)propane
1,3bis(diphenylphosphino)propane
propane-1,3-diylbis(diphenylphosphane)
1,3 bis(diphenylphosphino)propane
1,3-bis (diphenylphosphino) propane
1,3-bis(diphenylphophino)propane
1,3-bis(diphenylphosphine)-propane
1,3-bis(diphenylphosphine)propane
1,3-bis (diphenylphosphino)-propane
1,3-propanediylbis(diphenylphosphine)
1,3-bis-diphenylphosphinopropane
1,3-bis(diphenylphosphino) propane
1,3-bis (diphenylphosphino)propane
1,3bis-(diphenylphosphino)propane
DTXSID0064464
dppp [mi]
1,3-propylenebis(diphenylphosphine)
W-104717
STR02861
FD14028
phosphine, trimethylenebis(diphenyl-
[3-(diphenylphosphino)propyl](diphenyl)phosphine #
CS-W008852
BBL101642
F0001-1778
STL555438
BCP04337
Q161494
AMY19792
EN300-53864
PD159807
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID153809Maximum increase in life span was determined against P388 leukemia at 4-5 doses of compound1987Journal of medicinal chemistry, Dec, Volume: 30, Issue:12
Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds.
AID38071In vitro cytotoxicity against murine B16 melanoma cells1987Journal of medicinal chemistry, Dec, Volume: 30, Issue:12
Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds.
AID115142Maximally tolerated dose was measured after ip administration of compound, 24 hr after tumor implantation.1987Journal of medicinal chemistry, Dec, Volume: 30, Issue:12
Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's0 (0.00)18.2507
2000's4 (30.77)29.6817
2010's8 (61.54)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.04 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]